[{"Assets_0_Q3_USD":18375000.0,"CommonStockSharesOutstanding_0_Q3_shares":17219300.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-1925000.0,"NetIncomeLoss_1_Q3_USD":-697000.0,"NetIncomeLoss_3_Q3_USD":-3115000.0,"StockholdersEquity_0_Q3_USD":17445000.0,"Ticker":"SAVA","CIK":"1069530","name":"CASSAVA SCIENCES INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191029"}]